In silico design of anthraquinone-based two-photon photosensitisers for NIR-activated photodynamic therapy in hypoxic tumors
Source abstract
Abstract
A computational strategy is presented for the rational design of anthraquinone- based, heavy-atom–free photosensitizers optimized for two-photon photodynamic therapy in hypoxic tumors within NIR region. Twelve derivatives were evaluated for two-photon absorption, excited states dynamics, redox reactivity, and ADME properties. Four lead compounds— Oxz, Tdz, Prd, and Pmd— exhibited efficient Herzberg–Teller-enabled intersystem crossing, long triplet state lifetimes, and plausible phosphorescence quantum yields. The Redox Activity and Chemical Trends Map, validated against Marcus theory, distinguished distinct mechanistic profiles: Oxz favored Type I mechanism, Prd exhibited selective biomolecular oxidation (Type III), while Tdz and Pmd demonstrated broad- spectrum activity. Notably, Pmd retained reasonable phosphorescence rate despite concurrent processes, indicating sustained Type II reactivity under quenching. SwissADME analysis confirmed favorable permeability and synthetic accessibility. This integrative computational framework—though developed for anthraquinones—is generalizable to diverse scaffolds, enabling early-stage prioritization of oxygen-independent, multimodal two–photon PDT candidates for hypoxic cancer treatment.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Nonlinear Optical Materials Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (84)
Show source-provided references
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy
3. The pro-tumorigenic host response to cancer therapies10.1038/s41568-019-0209-6 ↗
4. Surgical complications of oncological treatments: a narrative review10.4240/wjgs.v15.i6.1056 ↗
5. Current states and future views in photodynamic therapy10.1016/j.jphotochemrev.2011.06.001 ↗
6. An updated overview on the development of new photosensitizers for anticancer photodynamic therapy10.1016/j.apsb.2017.09.003 ↗
7. Innovative strategies for photodynamic therapy against hypoxic tumor
8. The concept and examples of type-III photosensitizers for cancer photodynamic therapy10.1016/j.chempr.2021.10.006 ↗
9. Glutathione-responsive polymersome with continuous glutathione depletion for enhanced photodynamic therapy and hypoxia-activated chemotherapy10.1021/acsmacrolett.4c00125 ↗
10. Glutathione depletion and photosensitizer activation augments efficacy of tumor photodynamic immunotherapy10.1016/j.cej.2022.136170 ↗
11. A Microneedle Patch with self-Oxygenation and glutathione depletion for Repeatable photodynamic therapy10.1021/acsnano.2c08098 ↗
12. Ferroptosis and photodynamic therapy Synergism: enhancing anticancer treatment10.1016/j.trecan.2021.01.013 ↗
13. Type I photoreaction and photoinduced ferroptosis by a Ru(II) complex to overcome tumor Hypoxia in photodynamic therapy10.31635/ccschem.022.202202074 ↗
14. Triplet state. Its radiative and nonradiative properties10.1021/ar50001a002 ↗
15. Long‐lived charge‐transfer state induced by spin‐orbit charge transfer intersystem crossing (SOCT‐ISC) in a Compact Spiro electron donor/acceptor Dyad10.1002/anie.202003560 ↗
16. Spin–orbit charge‐transfer intersystem crossing (ISC) in Compact electron donor–acceptor Dyads: ISC mechanism and application as novel and potent photodynamic therapy Reagents10.1002/chem.201904306 ↗
17. Mitochondria-targeting hemicyanine photosensitizer as an inducer for MMP loss and cell apoptosis based on radical enhanced ISC strategy10.1016/j.snb.2023.134955 ↗
18. Radical enhanced intersystem crossing mechanism, electron spin dynamics of high spin states and their applications in the design of heavy atom-free triplet photosensitizers10.1039/D4OB00520A ↗
19. Thionation of conjugated porphyrin with enhanced photodynamic and photothermal effects for cancer therapy10.1016/j.jphotochem.2024.116085 ↗
20. Thionated Perylenebisimides as heavy‐atom‐free triplet photosensitizers: intersystem crossing, electron spin dynamics, and application in photodynamic therapy
21. Highly efficient photosensitizers with molecular vibrational torsion for cancer photodynamic therapy10.1021/acscentsci.3c00611 ↗
22. Soranjidiol as a photosensitizer: mechanistic insights into its photochemistry and photoinduced tautomerization10.1016/j.jphotobiol.2025.113203 ↗
23. Aggregation-induced emission photosensitizer-based photodynamic therapy in cancer: from chemical to clinical10.1186/s12951-022-01553-z ↗
24. Aggregation-induced emission photosensitizers: from molecular design to photodynamic therapy: Miniperspective10.1021/acs.jmedchem.9b02014 ↗
25. Aggregation suppresses internal conversion and enhances triplet yield in π-rich natural dyes by vibronic coupling control: A case study of hypericin supramolecular assembly
26. Anthraquinone-centered type I photosensitizer with aggregation-induced emission characteristics for tumor-targeted two-photon photodynamic therapy10.1021/acsmaterialslett.4c00600 ↗
27. Singlet fission initiating organic photosensitizations10.1038/s41598-023-50860-4 ↗
28. Aromaticity Tuning of heavy-atom-free photosensitizers for singlet fission-enhanced Immunogenic photodynamic Oncotherapy10.1021/acs.nanolett.4c01862 ↗
29. Singlet fission initiating triplet generations of BODIPY derivatives through $$\pi $$-stacking: a theoretical study10.1038/s41598-022-23370-y ↗
30. Measurement of the penetration depths of red and near infrared light in human “ex vivo” tissues10.1016/S1011-1344(00)00082-8 ↗
31. Optimising the design of a broad‐band light source for the treatment of skin10.1080/14764170500344575 ↗
32. Two-photon excitation photosensitizers for photodynamic therapy: from small-molecules to nano-complex systems10.1016/j.ccr.2024.215711 ↗
33. Development of a novel anti-tumor theranostic platform: a near-infrared molecular upconversion sensitizer for deep-seated cancer photodynamic therapy10.1039/C9SC04034J ↗
34. Two‐photon absorption and the design of two‐photon dyes10.1002/anie.200805257 ↗
35. “Competitive quenching”: a mechanism by which Perihydroxylated Perylenequinone photosensitizers can prevent Adverse phototoxic damage caused by Verteporfin during photodynamic therapy10.1111/j.1751-1097.2007.00171.x ↗
36. Journey of aggregation-induced emission research10.1021/acsomega.8b00062 ↗
37. On the photosensitizing properties of aloe-emodin in photodynamic therapy: insights from the molecular modeling10.1021/acs.jpcb.5c01117 ↗
38. Mechanistic and kinetic insights into rubiadin phototoxicity: Linking theory to photodynamic efficiency
39. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform10.1186/1758-2946-4-17 ↗
40. Multiwfn: a multifunctional wavefunction analyzer10.1002/jcc.22885 ↗
41. Second-harmonic generation of solvated molecules using multiconfigurational self-consistent-field quadratic response theory and the polarizable continuum model10.1063/1.2055180 ↗
42. Automated exploration of the low-energy chemical space with fast quantum chemical methods10.1039/C9CP06869D ↗
43. CREST—a program for the exploration of low-energy molecular chemical space10.1063/5.0197592 ↗
44. The ORCA quantum chemistry program package10.1063/5.0004608 ↗
45. Software update: the ORCA program system—Version 5.010.1002/wcms.1606 ↗
46. Comparative assessment of a new nonempirical density functional: molecules and hydrogen-bonded complexes10.1063/1.1626543 ↗
47. Recent developments in libxc — a comprehensive library of functionals for density functional theory10.1016/j.softx.2017.11.002 ↗
48. Balanced basis sets of split valence, triple zeta valence and quadruple zeta valence quality for H to Rn: design and assessment of accuracy10.1039/b508541a ↗
49. Extension of the D3 dispersion coefficient model10.1063/1.4993215 ↗
50. Universal solvation model based on Solute electron density and on a continuum model of the solvent defined by the Bulk Dielectric constant and atomic surface Tensions10.1021/jp810292n ↗
51. On the theoretical prediction of fluorescence rates from first principles using the path integral approach10.1063/1.5010895 ↗
52. Predicting phosphorescence rates of light organic molecules using time-dependent density functional theory and the path integral approach to dynamics10.1021/acs.jctc.8b00841 ↗
53. The importance of the electron spectrum in multi atomic molecules. Concerning the Franck-Condon principle
54. Time-dependent density functional theory within the Tamm–Dancoff approximation10.1016/S0009-2614(99)01149-5 ↗
55. Density-functional thermochemistry. III. The role of exact exchange10.1063/1.464913 ↗
56. Electron affinities of the first-row atoms revisited. Systematic basis sets and wave functions10.1063/1.462569 ↗
57. Gaussian basis sets for use in correlated molecular calculations. I. The atoms boron through neon and hydrogen10.1063/1.456153 ↗
58. A new integral equation formalism for the polarizable continuum model: theoretical background and applications to isotropic and anisotropic dielectrics10.1063/1.474659 ↗
59. The Dalton quantum chemistry program system10.1002/wcms.1172 ↗
60. Degenerate and non-degenerate two-photon absorption of coumarin dyes10.1039/D3CP00723E ↗
61. Benchmarking two-photon absorption cross sections: performance of CC2 and CAM-B3LYP10.1039/C5CP03241E ↗
62. Citric acid: a promising copper scavenger10.1016/j.comptc.2018.04.011 ↗
63. Electron transfers in chemistry and biology10.1016/0304-4173(85)90014-X ↗
64. CADMA-chem: a computational protocol based on chemical properties Aimed to design multifunctional Antioxidants
65. Estimation of electronic coupling for Intermolecular electron transfer from cross-reaction data10.1021/jp064406v ↗
66. Estimation of inner shell Marcus terms for amino nitrogen compounds by molecular orbital calculations10.1021/ja00237a007 ↗
67. The ups and downs of internal conversion10.1103/jgpv-232f ↗
68. Intersystem crossing driven by vibronic spin–orbit coupling: a case study on psoralen10.1039/b706410a ↗
69. Spin-vibronic mechanism for intersystem crossing10.1021/acs.chemrev.7b00617 ↗
70. Anthraquinone derivatives as sensitizers of the formation of singlet oxygen10.1007/BF00661049 ↗
71. Hydroxyanthraquinones as sensitizers of singlet oxygen reactions: quantum yields of triplet formation and singlet oxygen generation in acetonitrile10.1016/1010-6030(92)85273-W ↗
72. OGG1-initiated base excision repair exacerbates oxidative stress-induced parthanatos
73. Two distinct pathways of cell death triggered by oxidative damage to nuclear and mitochondrial DNAs10.1038/sj.emboj.7601975 ↗
74. Cysteine depletion, a key action to challenge cancer cells to Ferroptotic cell death10.3389/fonc.2020.00723 ↗
75. Glutathione depletion induces ferroptosis, autophagy, and premature cell senescence in retinal pigment epithelial cells10.1038/s41419-018-0794-4 ↗
76. Glutathione metabolism in ferroptosis and cancer therapy10.1016/j.canlet.2025.217697 ↗
77. Reactive oxygen species-induced lipid Peroxidation in apoptosis, autophagy, and ferroptosis
78. Plasma membrane integrity: implications for health and disease10.1186/s12915-021-00972-y ↗
79. Photochemistry and phototoxicity of aloe emodin10.1562/0031-8655(2002)0750346PAPOAE2.0.CO2 ↗
80. Binding of a homologous series of anthraquinones to DNA10.1016/j.bmcl.2003.10.054 ↗
81. Cyclic anthraquinone derivatives, unique G-quadruplex binders, selectively induce cancer cell apoptosis and inhibit tumor growth10.1093/pnasnexus/pgad211 ↗
82. DNA-binding, DNA cleavage and cytotoxicity studies of two anthraquinone derivatives10.1016/j.saa.2011.11.045 ↗
83. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules10.1038/srep42717 ↗
84. Perplexing role of P-glycoprotein in tumor microenvironment10.3389/fonc.2020.00265 ↗